Foscarnet for suppression of human immunodeficiency virus replication.

AUTOR(ES)

Fletcher, C V

RESUMO

The effect of foscarnet against human immunodeficiency virus (HIV) was evaluated in nine HIV-infected individuals; six completed 28 days of induction therapy. The overall mean increase in CD4+ lymphocytes was 64 cells per mm3. The mean decline in the HIV antigen concentration was 108 pg/ml (P = 0.03), and suppression was related to systemic foscarnet exposure by a maximum-effect pharmacodynamic model.

Documentos Relacionados

• The art gene product of human immunodeficiency virus is required for replication.
• Inhibitory effects of polyethers on human immunodeficiency virus replication.
• Entamoeba histolytica antigen-specific induction of human immunodeficiency virus replication.
• Oltipraz, an inhibitor of human immunodeficiency virus type 1 replication.
• The molecular target of bicyclams, potent inhibitors of human immunodeficiency virus replication.